Cargando…
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713277/ https://www.ncbi.nlm.nih.gov/pubmed/35914225 http://dx.doi.org/10.1182/bloodadvances.2022008395 |
_version_ | 1784841983474270208 |
---|---|
author | Shah, Hridaya Chen, Hang Pan, Xiang-Zuo Metjian, Ara Brodsky, Robert A. Braunstein, Evan M. Chaturvedi, Shruti |
author_facet | Shah, Hridaya Chen, Hang Pan, Xiang-Zuo Metjian, Ara Brodsky, Robert A. Braunstein, Evan M. Chaturvedi, Shruti |
author_sort | Shah, Hridaya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9713277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-97132772022-12-06 C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy Shah, Hridaya Chen, Hang Pan, Xiang-Zuo Metjian, Ara Brodsky, Robert A. Braunstein, Evan M. Chaturvedi, Shruti Blood Adv Research Letter The American Society of Hematology 2022-08-03 /pmc/articles/PMC9713277/ /pubmed/35914225 http://dx.doi.org/10.1182/bloodadvances.2022008395 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Letter Shah, Hridaya Chen, Hang Pan, Xiang-Zuo Metjian, Ara Brodsky, Robert A. Braunstein, Evan M. Chaturvedi, Shruti C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
title | C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
title_full | C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
title_fullStr | C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
title_full_unstemmed | C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
title_short | C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
title_sort | c5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713277/ https://www.ncbi.nlm.nih.gov/pubmed/35914225 http://dx.doi.org/10.1182/bloodadvances.2022008395 |
work_keys_str_mv | AT shahhridaya c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy AT chenhang c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy AT panxiangzuo c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy AT metjianara c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy AT brodskyroberta c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy AT braunsteinevanm c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy AT chaturvedishruti c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy |